Iguratimod

Iguratimod is a unique medication primarily used for the treatment of rheumatoid arthritis, a chronic autoimmune disorder characterized by inflammation and pain in the joints. This substance is a selective immunomodulator, which means it helps regulate the immune system’s response to reduce inflammation and alleviate symptoms.
Iguratimod works by inhibiting the activation of certain immune cells called T-cells, specifically those involved in the inflammatory process. By modulating the immune response, it helps to reduce the production of inflammatory cytokines, which are proteins that promote inflammation and joint damage.
The medication is available in tablet form and is typically prescribed for patients who have not responded well to conventional treatments, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Iguratimod may be used as a standalone therapy or in combination with other medications to manage the symptoms of rheumatoid arthritis more effectively.
Some potential side effects of Iguratimod may include headache, dizziness, and gastrointestinal issues such as nausea, diarrhea, or constipation. However, these side effects are generally mild and resolve on their own. Consult with a healthcare professional before starting treatment with Iguratimod to ensure it is the appropriate choice for the individual patient’s needs.